Columbia Laboratories develops drugs that improve treatment options for women’s reproductive healthcare using our novel bioadhesive delivery technologies, which optimize drug delivery in a controlled, sustained manner. Learn More
Columbia Laboratories Reports First Quarter 2013 Financial Results
Columbia Laboratories to Discuss First Quarter 2013 Financial Results on May 9 Conference Call
Columbia Laboratories Extends Agreement with Merck Serono for CRINONE Ex-U.S. into 2020
Columbia Laboratories Reports Fourth Quarter and Year-End 2012 Financial Results
Columbia Laboratories Extends Stockholder Rights Plan to Preserve Use of Net Operating Losses under Section 382
Download Columbia's current investor presentation: PDF »
05/09/2013 CBRX Q1 2013 financial conference call: Webcast
03/14/2013 CBRX Q4 and YE 2012 financial conference call: Webcast (archived)
03/06/2013 CBRX presentation at Cowen and Company Health Care Conference: Webcast (archived)
